THE LUPUS UK RANGE and Mixed Connective OF FACT SHEETS
may require steroids or immunosuppressants such as
A range of fact sheets are available as follows: Tissue Disease
Further investigations required according to specialist centre
and requires highly specialised management
Drugs used in MCTD
Steroids, either oral, intramuscular or intravenous, are used
when the disease is active in order to gain control. These are
often used for those with internal organ problems and drugs
that suppress the immune system, such as Methotrexate,
Azathioprine or Cyclophosphamide, are used to help reduce
the steroid dose over time and maintain remission. Whilst
these drugs do carry some significant potential side effects,
the risks of these are always outweighed by the risks of a very
active disease such as MCTD and doses are always kept to a
minimum to help reduce and minimise risk.
18. LUPUS and Mixed Connective Tissue Disease
LUPUS UK is the registered national charity caring for people with lupus and has over 6,000 members who are supported by the Regional Groups. Take home messages
LUPUS UK acknowledges with gratitude the assistance
of Sue Brown MSc RGN NIP EN (G) Consultant Nurse in
MCTD is a less commonly seen connective tissue disease that
Rheumatology (Connective Tissue Diseases) Royal
can cause a wide variety of different symptoms. Whilst some
National Hospital for Rheumatic Diseases NHS
can develop internal organ complications, this is not always
the case. There are three important messages for you to
Foundation, Bath in the provision of clinical information
towards the production of this fact sheet.
Learning to live with and finding ways to manage
your symptoms are important parts of coming to
(Northumberland) for their valued fundraising towards the
2. You can improve symptoms such as fatigue by
pacing and planning periods of activity and rest,
listening to your body and setting realistic achievable
Please contact National Office should you require further
goals (more information can be found about these in
information about lupus. LUPUS UK will be pleased to
provide a booklist and details of membership. 3. Pay attention to the variant or type of MCTD that you
have and keep in touch with your rheumatology team
if you develop any new symptoms or if you are at all
TEL: 01708 731251 www.lupusuk.org.uk
Joint pain and Painkillers such as Paracetamol or
ymptoms of MCTD
some, drugs like Hydroxychloroquine Rheumatoid or Methotrexate can be used. If
and Mixed Connective
The most commonly seen symptoms in MCTD include:
Tissue Disease hat is Mixed Connective Tissue Disease?
• Tight skin and/or ‘sausage-shaped’ digits
Mixed connective tissue disease (MCTD) is an auto-immune
• Dysphagia - Difficulty in swallowing
disease that was first recognised in 1972 and is considered to
• Trigeminal neuralgia – inflammation of the nerves affecting
be a cousin of lupus. We now understand that there can be an
overlap in many auto-immune diseases that may involve any
number of different variants of connective tissue diseases.
MCTD is the commonest seen combination, and symptoms of
Complications of MCTD
MCTD usually either appear as a lupus or a scleroderma
variant. Some people have a polymyositis variant so have
problems with muscle inflammation as well. Often with time,
Some people with MCTD can develop internal organ problems
MCTD may evolve into one of the conditions of lupus,
although this is rarer. All people with MCTD should pay
scleroderma or polymyositis. Dermatomyositis can also be
attention to any new episodes of breathlessness and/or heart
seen when the inflammation affects the skin as well as the
palpitations. Regular heart and lung investigations should
always be requested in order to look out for possible signs of
interstitial lung disease (ILD) or pulmonary hypertension. These
development of digital ulcers especially
conditions, although in some cases serious, are now much
iagnosing MCTD
better diagnosed and treated in specialist centres that see
people with MCTD on a regular basis. Investigations need to
be balanced according to symptoms and for many, these
For many, to gain a diagnosis of any connective tissue disease
is difficult and this is still the case for MCTD. As the immune
system is over-active in these conditions, most people with
MCTD will have positive Anti-Nuclear Antibodies (ANA) and
Treatments for MCTD
also antibodies to ribonuceloprotein (RNP). The specific
antibody for MCTD is called Anti-U1-RNP. Other diagnoses
should always be excluded before coming to a diagnosis of
Treatments for MCTD vary dependent on the types of
MCTD, especially in people who do not carry any MCTD
symptoms that you may have. The following table describes
some of the treatments used, but it is important to remember
that your specialist team will always assess how active your
disease is and suggest treatments according to your variant of
ho gets MCTD?
MCTD. This table describes the symptoms and important
points and in which variant you would expect these to occur.
As is seen in many other rheumatological conditions, more
Symptoms Treatments and important Associated
women than men have MCTD and it can occur at any age.
Children can be diagnosed with MCTD, where Raynaud's
phenomenon (a circulatory disorder affecting mostly the hands
and feet), fatigue and pain tend to be the commonest
symptoms. As signs and symptoms can change over time,
children with a diagnosis of MCTD should always be closely
monitored and these should be acted upon if any other
prevent side effects associated with medication
1. Last Name First Name DO NOT WRITE IN THIS SPACE N.C. Department of Health and Human Services State Laboratory of Public Health 2. Patient Number Submitter Laboratory/Medical Record #: _____________________ 3. Address _ t _ e _ _ o _ f PLEASE GIVE ALL Month Day Year INFORMATION REQUESTED 5. Race 1. White 2. Black 3. American Indian 4
Literatur 1. Adams T, Heisey RS, Smith MC, Briner BJ. Parietal bone mobility in the anesthetized cat. J Am Osteopath Assoc. 1992;92:599--622. Amprino R. Bone Histophysiology. Guy’s Hospital Rep. 1967;116:51--69. Andres KH. Über die Feinstruktur der Arachnoidea und Dura mater von Mammalia. Z Zellforsch. 1967;79:272--295. Australian Physiotherapy Association. Protocol after 6 years. Man T